一周医药速览(02.09-02.13)

财经网
Feb 13

信达生物:与礼来制药达成最高88.5亿美元的全球战略合作,推进肿瘤及免疫领域的新药开发近日,信达生物制药集团宣布与礼来制药达成战略合作,携手推进肿瘤及免疫领域创新药物的全球研发。本次协议为双方第七次合作,进一步深化了双方长期且富有成效的合作伙伴关系,携手为全球患者带来创新药物。根据合作协议,双方将发挥互补优势,加快推进创新药物的全球研发工作。信达生物依托自身成熟的抗体技术平台及高效的临床能力,将...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10